FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Polly Roy

Research Profile

Living Beings

Chemicals & Drugs

Anatomy

Co-author Network

Publications

TOP 3
Meredith Stewart; Richard Thiéry; Cyril Viarouge; Stéphan Zientara; Emmanuel Bréard; Alexandra Desprat; Eric Dubois; Corinne Sailleau; Polly Roy
Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen.
Bishnupriya Bhattacharya; Polly Roy
Cellular phosphoinositides and the maturation of bluetongue virus, a non-enveloped capsid virus.
Eiko Matsuo; Polly Roy
Minimum requirements for bluetongue virus primary replication in vivo.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Polly Roy (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Meredith Stewart; Richard Thiéry; Cyril Viarouge; Stéphan Zientara; Emmanuel Bréard; Alexandra Desprat; Eric Dubois; Corinne Sailleau; Polly Roy
Bluetongue virus serotype 8 virus-like particles protect sheep against virulent virus infection as a single or multi-serotype cocktail immunogen.
Vaccine 2013;31(3):553-8.
2013: Bishnupriya Bhattacharya; Polly Roy
Cellular phosphoinositides and the maturation of bluetongue virus, a non-enveloped capsid virus.
Virology journal 2013;10():73.
2013: Eiko Matsuo; Polly Roy
Minimum requirements for bluetongue virus primary replication in vivo.
Journal of virology 2013;87(2):882-9.
2012: M Stewart; TN Athmaram; E Chatzinasiou; Chrysostomos Dovas; Orestis Papadopoulos; Maria Papanastassopoulou; Polly Roy
Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
Vaccine 2012;30(12):2131-9.
2012: Mark Boyce; Cristina C P Celma; Polly Roy
Bluetongue virus non-structural protein 1 is a positive regulator of viral protein synthesis.
Virology journal 2012;9():178.
2011: Eiko Matsuo; Mark Boyce; Emmanuel Bréard; Cristina C P Celma; Eric Dubois; Corinne Sailleau; Richard Thiéry; Cyril Viarouge; Stéphan Zientara; Polly Roy
Generation of replication-defective virus-based vaccines that confer full protection in sheep against virulent bluetongue virus challenge.
Journal of virology 2011;85(19):10213-21.
2011: Sofia Lourenco; Polly Roy
In vitro reconstitution of Bluetongue virus infectious cores.
Proceedings of the National Academy of Sciences of the United States of America 2011;108(33):13746-51.
2011: Cristina C P Celma; Polly Roy
Interaction of calpactin light chain (S100A10/p11) and a viral NS protein is essential for intracellular trafficking of nonenveloped bluetongue virus.
Journal of virology 2011;85(10):4783-91.
2011: Eiko Matsuo; Polly Roy
Bluetongue virus VP1 polymerase activity in vitro: template dependency, dinucleotide priming and cap dependency.
PloS one 2011;6(11):e27702.
2010: Eiko Matsuo; Cristina C P Celma; Polly Roy
A reverse genetics system of African horse sickness virus reveals existence of primary replication.
FEBS letters 2010;584(15):3386-91.
2010: Bishnupriya Bhattacharya; Polly Roy
Role of lipids on entry and exit of bluetongue virus, a complex non-enveloped virus.
Viruses 2010;2(5):1218-35.
2010: M Stewart; Y Bhatia; TN Athmaram; Rob Noad; C Gastaldi; E Dubois; P Russo; R Thiéry; C Sailleau; E Bréard; S Zientara; Polly Roy
Validation of a novel approach for the rapid production of immunogenic virus-like particles for bluetongue virus.
Vaccine 2010;28(17):3047-54.
2010: Meredith E Stewart; Polly Roy
Role of cellular caspases, nuclear factor-kappa B and interferon regulatory factors in Bluetongue virus infection and cell fate.
Virology journal 2010;7():362.
2009: Eiko Matsuo; Polly Roy
Bluetongue virus VP6 acts early in the replication cycle and can form the basis of chimeric virus formation.
Journal of virology 2009;83(17):8842-8.
2009: Cristina C P Celma; Polly Roy
A viral nonstructural protein regulates bluetongue virus trafficking and release.
Journal of virology 2009;83(13):6806-16.
2009: Polly Roy; Mark Boyce; Robert Noad
Prospects for improved bluetongue vaccines.
Nature reviews. Microbiology 2009;7(2):120-8.
2009: Polly Roy; Rob Noad
Virus-like particles as a vaccine delivery system: myths and facts.
Advances in experimental medicine and biology 2009;655():145-58.
2009: Rob Noad; Meredith Stewart; Mark Boyce; Cristina C P Celma; Keith R Willison; Polly Roy
Multigene expression of protein complexes by iterative modification of genomic Bacmid DNA.
BMC molecular biology 2009;10():87.
2008: Bishnupriya Bhattacharya; Polly Roy
Bluetongue virus outer capsid protein VP5 interacts with membrane lipid rafts via a SNARE domain.
Journal of virology 2008;82(21):10600-12.
2008: Mark Boyce; Cristina C P Celma; Polly Roy
Development of reverse genetics systems for bluetongue virus: recovery of infectious virus from synthetic RNA transcripts.
Journal of virology 2008;82(17):8339-48.
2008: Polly Roy
Bluetongue virus: dissection of the polymerase complex.
The Journal of general virology 2008;89(Pt 8):1789-804.
2008: Li Liu; Cristina C P Celma; Polly Roy
Rift Valley fever virus structural proteins: expression, characterization and assembly of recombinant proteins.
Virology journal 2008;5():82.
2008: Polly Roy; Rob Noad
Virus-like particles as a vaccine delivery system: myths and facts.
Human vaccines 2008;4(1):5-12.
2008: Polly Roy
Functional mapping of bluetongue virus proteins and their interactions with host proteins during virus replication.
Cell biochemistry and biophysics 2008;50(3):143-57.
2007: Geoff Sutton; Jonathan M Grimes; David I Stuart; Polly Roy
Bluetongue virus VP4 is an RNA-capping assembly line.
Nature structural & molecular biology 2007;14(5):449-51.
2007: Josa-marie Wehrfritz; Mark Boyce; Sahdia Mirza; Polly Roy
Reconstitution of bluetongue virus polymerase activity from isolated domains based on a three-dimensional structural model.
Biopolymers 2007;86(1):83-94.
2007: Mario Forzan; Mark Marsh; Polly Roy
Bluetongue virus entry into cells.
Journal of virology 2007;81(9):4819-27.
2007: Mark Boyce; Polly Roy
Recovery of infectious bluetongue virus from RNA.
Journal of virology 2007;81(5):2179-86.
2007: Alak K. Kar; Bishnupriya Bhattacharya; Polly Roy
Bluetongue virus RNA binding protein NS2 is a modulator of viral replication and assembly.
BMC molecular biology 2007;8():4.
2007: Bishnupriya Bhattacharya; Rob Noad; Polly Roy
Interaction between Bluetongue virus outer capsid protein VP2 and vimentin is necessary for virus egress.
Virology journal 2007;4():7.
2006: Kostas Lymperopoulos; Rob Noad; Sara Tosi; Suran Nethisinghe; Ian Brierley; Polly Roy
Specific binding of Bluetongue virus NS2 to different viral plus-strand RNAs.
Virology 2006;353(1):17-26.
2006: Polly Roy; Rob Noad
Bluetongue virus assembly and morphogenesis.
Current topics in microbiology and immunology 2006;309():87-116.
2006: Christoph Wirblich; Bishnupriya Bhattacharya; Polly Roy
Nonstructural protein 3 of bluetongue virus assists virus release by recruiting ESCRT-I protein Tsg101.
Journal of virology 2006;80(1):460-73.
2005: Natasha Larke; Aileen Murphy; Christoph Wirblich; Denise Teoh; Marie J Estcourt; Andrew J McMichael; Polly Roy; Tomás Hanke
Induction of human immunodeficiency virus type 1-specific T cells by a bluetongue virus tubule-vectored vaccine prime-recombinant modified virus Ankara boost regimen.
Journal of virology 2005;79(23):14822-33.
2005: Alak K. Kar; Nao Iwatani; Polly Roy
Assembly and intracellular localization of the bluetongue virus core protein VP3.
Journal of virology 2005;79(17):11487-95.
2005: Jens Modrof; Kostas Lymperopoulos; Polly Roy
Phosphorylation of bluetongue virus nonstructural protein 2 is essential for formation of viral inclusion bodies.
Journal of virology 2005;79(15):10023-31.
2005: Polly Roy
Bluetongue virus proteins and particles and their role in virus entry, assembly, and release.
Advances in virus research 2005;64():69-123.
2004: Eduardo Mortola; Polly Roy
Efficient assembly and release of SARS coronavirus-like particles by a heterologous expression system.
FEBS letters 2004;576(1-2):174-8.
2004: Polly Roy
Genetically engineered structure-based vaccine for bluetongue disease.
Veterinaria italiana 2004;40(4):594-600.
2004: Emma L Nason; Rosalba Rothagel; Sharmila K Mukherjee; Alak K. Kar; Mario Forzan; B V Venkataram Prasad; Polly Roy
Interactions between the inner and outer capsids of bluetongue virus.
Journal of virology 2004;78(15):8059-67.
2004: Alak K. Kar; Mrinal Ghosh; Polly Roy
Mapping the assembly pathway of Bluetongue virus scaffolding protein VP3.
Virology 2004;324(2):387-99.
2004: Randall J Owens; Chang Kwang Limn; Polly Roy
Role of an arbovirus nonstructural protein in cellular pathogenesis and virus release.
Journal of virology 2004;78(12):6649-56.
2004: Mark Boyce; Josa Wehrfritz; Rob Noad; Polly Roy
Purified recombinant bluetongue virus VP1 exhibits RNA replicase activity.
Journal of virology 2004;78(8):3994-4002.
2004: Eduardo Mortola; Rob Noad; Polly Roy
Bluetongue virus outer capsid proteins are sufficient to trigger apoptosis in mammalian cells.
Journal of virology 2004;78(6):2875-83.
2004: Mario Forzan; Christoph Wirblich; Polly Roy
A capsid protein of nonenveloped Bluetongue virus exhibits membrane fusion activity.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(7):2100-5.
2003: Alak K. Kar; Polly Roy
Defining the structure-function relationships of bluetongue virus helicase protein VP6.
Journal of virology 2003;77(21):11347-56.
2003: Chang Kwang Limn; Polly Roy
Intermolecular interactions in a two-layered viral capsid that requires a complex symmetry mismatch.
Journal of virology 2003;77(20):11114-24.
2003: Rob Noad; Polly Roy
Virus-like particles as immunogens.
Trends in microbiology 2003;11(9):438-44.
2003: Kostas Lymperopoulos; Christoph Wirblich; Ian Brierley; Polly Roy
Sequence specificity in the interaction of Bluetongue virus non-structural protein 2 (NS2) with viral RNA.
The Journal of biological chemistry 2003;278(34):31722-30.
2003: Polly Roy
Nature and duration of protective immunity to bluetongue virus infection.
Developments in biologicals 2003;114():169-83.
2002: Mrinal K Ghosh; M V Borca; Polly Roy
Virus-derived tubular structure displaying foreign sequences on the surface elicit CD4+ Th cell and protective humoral responses.
Virology 2002;302(2):383-92.
2002: Andrew R Beaton; Javier Rodriguez; Y Krishnamohan Reddy; Polly Roy
The membrane trafficking protein calpactin forms a complex with bluetongue virus protein NS3 and mediates virus release.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(20):13154-9.
2002: Naresh K Kakker; Michael V Mikhailov; Ian M Jones; Polly Roy
Comparative analysis of the roles of simian immunodeficiency and bovine leukemia virus matrix proteins in Gag assembly in insect cells.
Virology 2002;299(1):48-55.
2002: Mrinal K Ghosh; Cui-Ling Li; Catherine Fayolle; Gilles Dadaglio; Aileen Murphy; François A Lemonnier; Polly Roy; CLAUDE LECLERC
Induction of HLA-A2-restricted CTL responses by a tubular structure carrying human melanoma epitopes.
Vaccine 2002;20(19-20):2463-73.
2002: Mrinal K Ghosh; Edith Dériaud; Marie-Françoise Saron; Richard Lo-Man; Thomas Henry; Xinan Jiao; Polly Roy; CLAUDE LECLERC
Induction of protective antiviral cytotoxic T cells by a tubular structure capable of carrying large foreign sequences.
Vaccine 2002;20(9-10):1369-77.
2001: S H Hassan; Christoph Wirblich; Mario Forzan; Polly Roy
Expression and functional characterization of bluetongue virus VP5 protein: role in cellular permeabilization.
Journal of virology 2001;75(18):8356-67.
2001: B H Tan; E Nason; N Staeuber; W Jiang; K Monastryrskaya; Polly Roy
RGD tripeptide of bluetongue virus VP7 protein is responsible for core attachment to Culicoides cells.
Journal of virology 2001;75(8):3937-47.
2000: Chang Kwang Limn; N Staeuber; K Monastyrskaya; Patrice Gouet; Polly Roy
Functional dissection of the major structural protein of bluetongue virus: identification of key residues within VP7 essential for capsid assembly.
Journal of virology 2000;74(18):8658-69.
2000: Nigel Horscroft; Polly Roy
NTP binding and phosphohydrolase activity associated with purified bluetongue virus non-structural protein NS2.
The Journal of general virology 2000;81(Pt 8):1961-5.
1999: N K Kakker; Michael V Mikhailov; M V Nermut; A Burny; Polly Roy
Bovine leukemia virus Gag particle assembly in insect cells: formation of chimeric particles by domain-switched leukemia/lentivirus Gag polyprotein.
Virology 1999;265(2):308-18.
1999: S S Hassan; Polly Roy
Expression and functional characterization of bluetongue virus VP2 protein: role in cell entry.
Journal of virology 1999;73(12):9832-42.
1998: N Ramadevi; N J Burroughs; P P Mertens; I M Jones; Polly Roy
Capping and methylation of mRNA by purified recombinant VP4 protein of bluetongue virus.
Proceedings of the National Academy of Sciences of the United States of America 1998;95(23):13537-42.
1998: N Ramadevi; Polly Roy
Bluetongue virus core protein VP4 has nucleoside triphosphate phosphohydrolase activity.
The Journal of general virology 1998;79 ( Pt 10)():2475-80.
1998: J Martinez-Costas; Geoff Sutton; N Ramadevi; Polly Roy
Guanylyltransferase and RNA 5'-triphosphatase activities of the purified expressed VP4 protein of bluetongue virus.
Journal of molecular biology 1998;280(5):859-66.
1998: OB Bansal; A Stokes; Anju Bansal; D Bishop; Polly Roy
Membrane organization of bluetongue virus nonstructural glycoprotein NS3.
Journal of virology 1998;72(4):3362-9.
1998: N Ramadevi; J Rodriguez; Polly Roy
A leucine zipper-like domain is essential for dimerization and encapsidation of bluetongue virus nucleocapsid protein VP4.
Journal of virology 1998;72(4):2983-90.
1998: Polly Roy; Geoff Sutton
New generation of African horse sickness virus vaccines based on structural and molecular studies of the virus particles.
Archives of virology. Supplementum 1998;14():177-202.
1998: C F Williams; T Inoue; A M Lucus; Pablo M Zanotto; Polly Roy
The complete sequence of four major structural proteins of African horse sickness virus serotype 6: evolutionary relationships within and between the orbiviruses.
Virus research 1998;53(1):53-73.
1997: K Monastyrskaya; N Staeuber; Geoff Sutton; Polly Roy
Effects of domain-switching and site-directed mutagenesis on the properties and functions of the VP7 proteins of two orbiviruses.
Virology 1997;237(2):217-27.
1997: N Stäuber; J Martinez-Costas; Geoff Sutton; K Monastyrskaya; Polly Roy
Bluetongue virus VP6 protein binds ATP and exhibits an RNA-dependent ATPase function and a helicase activity that catalyze the unwinding of double-stranded RNA substrates.
Journal of virology 1997;71(10):7220-6.
1997: Ajit K Basak; Jonathan M Grimes; Patrice Gouet; Polly Roy; David I Stuart
Structures of orbivirus VP7: implications for the role of this protein in the viral life cycle.
Structure (London, England : 1993) 1997;5(7):871-83.
1997: Jonathan M Grimes; J Jakana; M Ghosh; Ajit K Basak; Polly Roy; W Chiu; David I Stuart; B V Prasad
An atomic model of the outer layer of the bluetongue virus core derived from X-ray crystallography and electron cryomicroscopy.
Structure (London, England : 1993) 1997;5(7):885-93.
1997: Polly Roy; Michael V Mikhailov; D H Bishop
Baculovirus multigene expression vectors and their use for understanding the assembly process of architecturally complex virus particles.
Gene 1997;190(1):119-29.
1996: Polly Roy; D H Bishop; S Howard; H Aitchison; B Erasmus
Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge.
The Journal of general virology 1996;77 ( Pt 9)():2053-7.
1996: Polly Roy
Multiple gene expression in baculovirus system. Third generation vaccines for bluetongue disease and African horsesickness disease.
Annals of the New York Academy of Sciences 1996;791():318-32.
1996: C K Yi; O B Bansal; M L Hong; S Chatterjee; Polly Roy
Sequences within the VP6 molecule of bluetongue virus that determine cytoplasmic and nuclear targeting of the protein.
Journal of virology 1996;70(7):4778-82.
1996: Ajit K Basak; Patrice Gouet; J Grimes; Polly Roy; David Stuart
Crystal structure of the top domain of African horse sickness virus VP7: comparisons with bluetongue virus VP7.
Journal of virology 1996;70(6):3797-806.
1996: M Mikhailov; K Monastyrskaya; Talitha Bakker; Polly Roy
A new form of particulate single and multiple immunogen delivery system based on recombinant bluetongue virus-derived tubules.
Virology 1996;217(1):323-31.
1996: Polly Roy
Orbivirus structure and assembly.
Virology 1996;216(1):1-11.
1996: Polly Roy
Genetically engineered particulate virus-like structures and their use as vaccine delivery systems.
Intervirology 1996;39(1-2):62-71.
1995: S Tanaka; M Mikhailov; Polly Roy
Synthesis of bluetongue virus chimeric VP3 molecules and their interactions with VP7 protein to assemble into virus core-like particles.
Virology 1995;214(2):593-601.
1995: K Monastyrskaya; Ernest A Gould; Polly Roy
Characterization and modification of the carboxy-terminal sequences of bluetongue virus type 10 NS1 protein in relation to tubule formation and location of an antigenic epitope in the vicinity of the carboxy terminus of the protein.
Journal of virology 1995;69(5):2831-41.
1995: A S Belyaev; R S Hails; Polly Roy
High-level expression of five foreign genes by a single recombinant baculovirus.
Gene 1995;156(2):229-33.
1995: J Grimes; Ajit K Basak; Polly Roy; David Stuart
The crystal structure of bluetongue virus VP7.
Nature 1995;373(6510):167-70.
1995: I Polkinghorne; Polly Roy
Transient expression in insect cells using a recombinant baculovirus synthesising bacteriophage T7 RNA polymerase.
Nucleic acids research 1995;23(1):188-91.
1994: Polly Roy; D H Bishop; H LeBlois; B J Erasmus
Long-lasting protection of sheep against bluetongue challenge after vaccination with virus-like particles: evidence for homologous and partial heterologous protection.
Vaccine 1994;12(9):805-11.
1994: S Tanaka; Polly Roy
Identification of domains in bluetongue virus VP3 molecules essential for the assembly of virus cores.
Journal of virology 1994;68(5):2795-802.
1994: Y Zhao; C Thomas; C Bremer; Polly Roy
Deletion and mutational analyses of bluetongue virus NS2 protein indicate that the amino but not the carboxy terminus of the protein is critical for RNA-protein interactions.
Journal of virology 1994;68(4):2179-85.
1994: K Monastyrskaya; T Booth; Louis Nel; Polly Roy
Mutation of either of two cysteine residues or deletion of the amino or carboxy terminus of nonstructural protein NS1 of bluetongue virus abrogates virus-specified tubule formation in insect cells.
Journal of virology 1994;68(4):2169-78.
1994: Y Zhoa; I M Jones; DJ Hockley; Milan V Nermut; Polly Roy
Complementation of human immunodeficiency virus (HIV-1) gag particle formation.
Virology 1994;199(2):403-8.
1993: Polly Roy
Dissecting the assembly of orbiviruses.
Trends in microbiology 1993;1(8):299-305.
1993: A S Belyaev; Polly Roy
Development of baculovirus triple and quadruple expression vectors: co-expression of three or four bluetongue virus proteins and the synthesis of bluetongue virus-like particles in insect cells.
Nucleic acids research 1993;21(5):1219-23.
1993: B P Hughes; T F Booth; A S Belyaev; D McIlroy; J Jowett; Polly Roy
Morphogenic capabilities of human immunodeficiency virus type 1 gag and gag-pol proteins in insect cells.
Virology 1993;193(1):242-55.
1993: H Le Blois; Polly Roy
A single point mutation in the VP7 major core protein of bluetongue virus prevents the formation of core-like particles.
Journal of virology 1993;67(1):353-9.
1992: Polly Roy
Bluetongue virus proteins.
The Journal of general virology 1992;73 ( Pt 12)():3051-64.
1992: Polly Roy
From genes to complex structures of bluetongue virus and their efficacy as vaccines.
Veterinary microbiology 1992;33(1-4):155-68.
1992: P T Loudon; Polly Roy
Interaction of nucleic acids with core-like and subcore-like particles of bluetongue virus.
Virology 1992;191(1):231-6.
1992: A S Belyaev; Polly Roy
Presentation of hepatitis B virus preS2 epitope on bluetongue virus core-like particles.
Virology 1992;190(2):840-4.
1992: H M Liu; T F Booth; Polly Roy
Interactions between bluetongue virus core and capsid proteins translated in vitro.
The Journal of general virology 1992;73 ( Pt 10)():2577-84.
1992: H Le Blois; T French; Peter P C Mertens; JN Burroughs; Polly Roy
The expressed VP4 protein of bluetongue virus binds GTP and is the candidate guanylyl transferase of the virus.
Virology 1992;189(2):757-61.
1992: Polly Roy; T French; B J Erasmus
Protective efficacy of virus-like particles for bluetongue disease.
Vaccine 1992;10(1):28-32.
1991: H Le Blois; B Fayard; T Urakawa; Polly Roy
Synthesis and characterization of chimeric particles between epizootic hemorrhagic disease virus and bluetongue virus: functional domains are conserved on the VP3 protein.
Journal of virology 1991;65(9):4821-31.
1991: P T Loudon; T Hirasawa; S Oldfield; M Murphy; Polly Roy
Expression of the outer capsid protein VP5 of two bluetongue viruses, and synthesis of chimeric double-shelled virus-like particles using combinations of recombinant baculoviruses.
Virology 1991;182(2):793-801.
1991: S Oldfield; T Hirasawa; Polly Roy
Sequence conservation of the outer capsid protein, VP5, of bluetongue virus, a contrasting feature to the outer capsid protein VP2.
The Journal of general virology 1991;72 ( Pt 2)():449-51.
1991: P T Loudon; Polly Roy
Assembly of five bluetongue virus proteins expressed by recombinant baculoviruses: inclusion of the largest protein VP1 in the core and virus-like proteins.
Virology 1991;180(2):798-802.
1990: Polly Roy
Use of baculovirus expression vectors: development of diagnostic reagents, vaccines and morphological counterparts of bluetongue virus.
FEMS microbiology immunology 1990;2(4):223-34.
1990: S Oldfield; A Adachi; T Urakawa; T Hirasawa; Polly Roy
Purification and characterization of the major group-specific core antigen VP7 of bluetongue virus synthesized by a recombinant baculovirus.
The Journal of general virology 1990;71 ( Pt 11)():2649-56.
1990: C P Thomas; T F Booth; Polly Roy
Synthesis of bluetongue virus-encoded phosphoprotein and formation of inclusion bodies by recombinant baculovirus in insect cells: it binds the single-stranded RNA species.
The Journal of general virology 1990;71 ( Pt 9)():2073-83.
1990: J J Marshall; B Fayard; Polly Roy
Biophysical studies on the morphology of baculovirus-expressed bluetongue virus tubules.
The Journal of general virology 1990;71 ( Pt 8)():1839-44.
1990: T J French; Polly Roy
Synthesis of bluetongue virus (BTV) corelike particles by a recombinant baculovirus expressing the two major structural core proteins of BTV.
Journal of virology 1990;64(4):1530-6.
1990: J J Marshall; Polly Roy
High level expression of the two outer capsid proteins of bluetongue virus serotype 10: their relationship with the neutralization of virus infection.
Virus research 1990;15(3):189-95.
1990: Polly Roy; A Adachi; T Urakawa; T F Booth; C P Thomas
Identification of bluetongue virus VP6 protein as a nucleic acid-binding protein and the localization of VP6 in virus-infected vertebrate cells.
Journal of virology 1990;64(1):1-8.
1988: T Urakawa; Polly Roy
Bluetongue virus tubules made in insect cells by recombinant baculoviruses: expression of the NS1 gene of bluetongue virus serotype 10.
Journal of virology 1988;62(11):3919-27.
1980: K C Gupta; Polly Roy
Alternate capping mechanisms for transcription of spring viremia of carp virus: evidence for independent mRNA initiation.
Journal of virology 1980;33(1):292-303.
1979: K C Gupta; D H Bishop; Polly Roy
5'-terminal sequences of spring viremia of carp virus RNA synthesized in vitro.
Journal of virology 1979;30(3):735-45.